Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases? von Nomiyama, Takashi

Volltext

SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation von Komatsu, Shiho, Nomiyama, Takashi, Numata, Tomohiro, Kawanami, Takako, Hamaguchi, Yuriko, Iwaya, Chikayo, Horikawa, Tsuyoshi, Fujimura-Tanaka, Yuki, Hamanoue, Nobuya, Motonaga, Ryoko, Tanabe, Makito, Inoue, Ryuji, Yanase, Toshihiko, Kawanami, Daiji

Volltext

Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4 von ARAKAWA, Masayuki, MITA, Tomoya, AZUMA, Kosuke, EBATO, Chie, GOTO, Hiromasa, NOMIYAMA, Takashi, FUJITANI, Yoshio, HIROSE, Takahisa, KAWAMORI, Ryuzo, WATADA, Hirotaka

Volltext

GLP-1 Receptor Agonist Exendin-4 Attenuates NR4A Orphan Nuclear Receptor NOR1 Expression in Vascular Smooth Muscle Cells von Takahashi, Hiroyuki, Nomiyama, Takashi, Terawaki, Yuichi, Kawanami, Takako, Hamaguchi, Yuriko, Tanaka, Tomoko, Tanabe, Makito, Bruemmer, Dennis, Yanase, Toshihiko

Volltext

Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases? von Takashi Nomiyama

Volltext

Sodium-glucose cotransporter 2 inhibitor canagliflozin attenuates lung cancer cell proliferation in vitro von Yamamoto, Leona, Yamashita, Shinichi, Nomiyama, Takashi, Kawanami, Takako, Hamaguchi, Yuriko, Shigeoka, Toru, Horikawa, Tsuyoshi, Tanaka, Yuki, Yanase, Toshihiko, Kawanami, Daiji, Iwasaki, Akinori

Volltext

High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men von Fujihara, Yuya, Hamanoue, Nobuya, Yano, Hiromi, Tanabe, Makito, Akehi, Yuko, Nomiyama, Takashi, Yanase, Toshihiko

Volltext

Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial von Morimoto, Takeshi, Sakuma, Ichiro, Sakuma, Mio, Tokushige, Akihiro, Natsuaki, Masahiro, Asahi, Tomohiro, Shimabukuro, Michio, Nomiyama, Takashi, Arasaki, Osamu, Node, Koichi, Ueda, Shinichiro

Volltext

Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice von Ervinna, Nasib, Mita, Tomoya, Yasunari, Eisuke, Azuma, Kosuke, Tanaka, Rica, Fujimura, Satoshi, Sukmawati, Dewi, Nomiyama, Takashi, Kanazawa, Akio, Kawamori, Ryuzo, Fujitani, Yoshio, Watada, Hirotaka

Volltext

A simple questionnaire for the detection of testosterone deficiency in men with late-onset hypogonadism von Akehi, Yuko, Tanabe, Makito, Yano, Hiromi, Takashi, Yuichi, Kawanami, Daiji, Nomiyama, Takashi, Yanase, Toshihiko

Volltext

Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth von Nomiyama, Takashi, Kawanami, Takako, Irie, Shinichiro, Hamaguchi, Yuriko, Terawaki, Yuichi, Murase, Kunitaka, Tsutsumi, Yoko, Nagaishi, Ryoko, Tanabe, Makito, Morinaga, Hidetaka, Tanaka, Tomoko, Mizoguchi, Makio, Nabeshima, Kazuki, Tanaka, Masatoshi, Yanase, Toshihiko

Volltext

Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy von Furuhashi, Masato, Sakuma, Ichiro, Morimoto, Takeshi, Higashiura, Yukimura, Sakai, Akiko, Matsumoto, Megumi, Sakuma, Mio, Shimabukuro, Michio, Nomiyama, Takashi, Arasaki, Osamu, Node, Koichi, Ueda, Shinichiro

Volltext

Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line von Fukuda, Takashi, Tanaka, Tomoko, Hamaguchi, Yuriko, Kawanami, Takako, Nomiyama, Takashi, Yanase, Toshihiko

Volltext

Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database von Tanabe, Makito, Motonaga, Ryoko, Terawaki, Yuichi, Nomiyama, Takashi, Yanase, Toshihiko

Volltext

Efficacy and safety of sodium–glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus;... von Nomiyama, Takashi, Shimono, Dai, Horikawa, Tsuyoshi, Fujimura, Yuki, Ohsako, Tomohiro, Terawaki, Yuichi, Fukuda, Takashi, Motonaga, Ryoko, Tanabe, Makito, Yanase, Toshihiko, Collaborators of Fukuoka Study of Ipragliflozin (FUSION) trial

Volltext

Total testosterone is the most valuable indicator of metabolic syndrome among various testosterone values in middle-aged Japanese men von Tanabe, Makito, Akehi, Yuko, Nomiyama, Takashi, Murakami, Junji, Yanase, Toshihiko

Volltext

Combined treatment with glucagon-like peptide-1 receptor agonist exendin-4 and metformin attenuates breast cancer growth von Tanaka, Yuki, Iwaya, Chikayo, Kawanami, Takako, Hamaguchi, Yuriko, Horikawa, Tsuyoshi, Shigeoka, Toru, Yanase, Toshihiko, Kawanami, Daiji, Nomiyama, Takashi

Volltext

Activation of overexpressed glucagon‐like peptide‐1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression von Shigeoka, Toru, Nomiyama, Takashi, Kawanami, Takako, Hamaguchi, Yuriko, Horikawa, Tsuyoshi, Tanaka, Tomoko, Irie, Shinichiro, Motonaga, Ryoko, Hamanoue, Nobuya, Tanabe, Makito, Nabeshima, Kazuki, Tanaka, Masatoshi, Yanase, Toshihiko, Kawanami, Daiji

Volltext

Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving st... von Furuhashi, Masato, Sakuma, Ichiro, Morimoto, Takeshi, Higashiura, Yukimura, Sakai, Akiko, Matsumoto, Megumi, Sakuma, Mio, Shimabukuro, Michio, Nomiyama, Takashi, Arasaki, Osamu, Node, Koichi, Ueda, Shinichiro

Volltext

Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth von Tsutsumi, Yoko, Nomiyama, Takashi, Kawanami, Takako, Hamaguchi, Yuriko, Terawaki, Yuichi, Tanaka, Tomoko, Murase, Kunitaka, Motonaga, Ryoko, Tanabe, Makito, Yanase, Toshihiko

Volltext